New Drug Approvals

JANUARY 9, 2024

As such, it has been proposed that inhibiting CDK7 would provide a potent means of inhibiting cell cycle progression, which may be especially relevant given that there is compelling evidence from gene knockout studies in mice for lack of an absolute requirement for CDK2, CDK4 and CDK6 for the cell cycle at least in most cell types (M alumbres et al.,

Production 62

Production DNA RNA Regulations 62

The Pharma Data

OCTOBER 19, 2020

USA) from the period of 2006 to 2016. in Cell Biology from Utrecht University. Prior to Aduro, Dr. van de Laar held various development and manufacturing positions at MSD (trademark of Merck & Co., Kenilworth, N.J., Dr. van de Laar holds a M.Sc. in Bioprocess Technology from Wageningen University and a Ph.D. About AM-Pharma.

Trials 40

Trials Small Molecule Cell Biology Clinical Trials 40

Codon

OCTOBER 22, 2024

As another example of how peer review can be augmented, The Journal of Cell Biology has successfully implemented an “ image integrity check ” to help cut down on improper image manipulation. in physics from Stony Brook University in 2016. He obtained his Ph.D. You can find him on X at @moreisdifferent.

Science 120

Science Research Government Cell Biology 120

Broad Institute

JULY 28, 2023

He is the recipient of several honors and fellowships, including a research scholarship from the German Research Foundation and NARSAD Young Investigator Awards in 2016 and 2022. in molecular and cell biology and biochemistry from the University of Oxford.

Medical Schools 52

Medical Schools Hospitals Regulations Research 52

Codon

SEPTEMBER 22, 2024

Building on years of research into stem cells and reproductive development, 1 the researchers, led by Professor Katsuhiko Hayashi , developed a method to induce male stem cells to lose their Y chromosome and duplicate the X chromosome, thus becoming female. For nearly all of human history, there was only one way to make a baby.

DNA 122

DNA Laboratories Regulations Therapies 122

Drug Target Review

JANUARY 16, 2025

She has a PhD in Microbiology and Cell Biology from the University of Illinois, followed by work in biochemistry as a post-doctoral fellow at UCSF. Journal of Medicinal Chemistry , 59(6):23122327, 2016. Ajay N Jain Ajay is VP of Research for the Optibrium s BioPharmics Division. Doak BC, Zheng J, Dobritzsch D, Kihlberg J.

Drug Development 52

Drug Development Small Molecule Drugs FDA Approval 52

Codon

AUGUST 10, 2023

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). . & Weiss R.

DNA 98

DNA Cell Biology Molecular Biology Engineering 98

Drug Target Review

MARCH 26, 2025

2016 Dec;5(6):877-884. She has a background in cell biology, biophysics and pharmacology and was a professor and Chair at the University of Kansas for over 20 years. J Endocr Soc. 2020 Oct 30;5(1):bvaa161. doi: 10.1210/jendso/bvaa161. PMID: 33294762; PMCID: PMC7705876. [7] 7] Unger CA. Hormone therapy for transgender patients.

Therapies 52

Therapies Compliance Treatment Small Molecule 52

Codon

AUGUST 10, 2023

Nature Reviews Molecular Cell Biology (2009). Link The second decade of synthetic biology: 2010–2020 , by Meng F. & Link Synthetic biology in mammalian cells: next generation research tools and therapeutics , by Lienert F. Nature Reviews Molecular Cell Biology (2014). . & Weiss R.

DNA 52

DNA Cell Biology Engineering Molecular Biology 52